Cerenome (CNSY) EBT Margin (2011 - 2026)
Powered by 
Analysis
Cerenome (CNSY) EBT Margin (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 35.71% |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | -528.97% |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 18.33% |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 13.77% |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 12.09% |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | -2.67% |
| 10 | Cerenome | 20.42 Mn | 11.83 Mn | - | -2,191.24% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,191.24% |
| Mar 31, 2026 | -675.68% |
| Dec 31, 2025 | -417.92% |
| Sep 30, 2025 | -316.61% |
| Jun 30, 2025 | -108.71% |
| Mar 31, 2025 | -385.55% |
| Dec 31, 2024 | -276.42% |
| Sep 30, 2024 | -259.62% |
| Jun 30, 2024 | -285.93% |
| Mar 31, 2024 | -194.45% |
| Dec 31, 2023 | -290.18% |
| Sep 30, 2023 | -73.16% |
| Jun 30, 2023 | -78.00% |
| Mar 31, 2023 | -949.60% |
| Dec 31, 2022 | -3,715.23% |
| Sep 30, 2022 | -7,186.30% |
| Mar 31, 2019 | -380.37% |
| Dec 31, 2018 | -171.59% |
| Sep 30, 2018 | -318.07% |
| Jun 30, 2018 | -346.21% |